.Completing passions.R.S., M.S., H.G. and A.A.R. are actually organizers of the 1M1M campaign.
H.G. and also A.A.R. are actually panel of supervisors participants and R.S., M.S.
and A.A.R. are actually members of the medical advisory committee of N1C. A.A.R.
reveals employment by LUMC, which has patents on exon-skipping modern technology, some of which has actually been actually certified to BioMarin and subsequently sublicensed to Sarepta. As co-inventor of a number of these licenses, A.A.R. was allowed to a reveal of royalties.
A.A.R. even further discloses functioning as consultant for PTC Rehabs, Sarepta Therapeutics, Regenxbio, Dyne Therapies, Lilly, BioMarin Pharmaceuticals Inc., Eisai, Entrada, Takeda, Splicesense, Galapagos, Sapreme, Italfarmaco and also Astra Zeneca. Before 5 years, A.A.R.
additionally performed ad hoc seeking advice from for Alpha Anomeric. A.A.R. also states membership of the medical boards of advisers of Eisai, Hybridize Therapeutics, Muteness Therapies, Sarepta Rehabs, Sapreme as well as Mitorx.
Before 5 years, A.A.R. was likewise a scientific advisory board member for ProQR. Pay for A.A.R.
u00e2 s consulting and urging activities is actually paid for to LUMC. Before 5 years, LUMC likewise obtained audio speaker gratuity from PTC Therapies, Alnylam Netherlands, Italfarmaco as well as Pfizer as well as moneying for contract research study coming from Sapreme, Eisai, Galapagos, Synaffix and Alpha Anomeric. Job backing is actually gotten from Sarepta Rehabs as well as Entrada through unregulated gives.
H.G. possesses nothing at all to disclose in relation to the subjects dealt with in this composition. Previously 5 years, he has likewise obtained working as a consultant honoraria coming from UCB.
M.S. received working as a consultant gratuity coming from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly and Solaxa over the last 5 years, all irrelevant to the present document. R.S.
possesses absolutely nothing to disclose in relation to the subject matters dealt with within this document. She has obtained audio speaker and/or working as a consultant gratuity or even funding payments coming from Abbvie, Bial, STADA as well as Everpharma before 5 years.